Desire fades. Arousal becomes unreliable. Sensitivity diminishes. The experience changes in ways that feel isolating and impossible to discuss. But sexual dysfunction is not psychological — it is hormonal. Testosterone, estrogen, DHEA, thyroid, vascular health — every axis of sexual function maps to a measurable biomarker. The answer is in the labs no one thought to run.
Get the Real AnswerSexual function is not one system. It is an intersection of desire, arousal, sensitivity, performance, and satisfaction — each governed by specific hormones. When any driver falls out of range, the downstream effect is felt immediately.
The primary driver of male libido. Declining free testosterone — not total — determines whether desire is present or absent. Standard panels rarely test free testosterone.
Excess estrogen in men impairs arousal, reduces erectile quality, and drives weight gain. The testosterone-to-estradiol ratio matters more than either value alone.
The precursor hormone that feeds both testosterone and estrogen production. Low DHEA-S signals depleted hormonal reserves — a root cause standard panels never check.
Women produce testosterone too — and it drives desire just as powerfully. Female testosterone decline is the most underdiagnosed cause of low libido. It is almost never tested in conventional care.
Estrogen maintains vaginal tissue, lubrication, and nerve sensitivity. Progesterone modulates mood and relaxation. When both decline — perimenopause, postpartum — sexual function collapses across every dimension.
Chronically elevated cortisol suppresses all reproductive hormones. Stress is not just a mood-killer — it is a hormone-killer. The body prioritizes survival over reproduction.
A standard assessment for sexual dysfunction typically checks total testosterone (men) or nothing hormonal at all (women). That misses the majority of hormonal causes. Here is what comprehensive testing looks like.
Sexual health responds to precision. Each of these addresses a different layer of the dysfunction — and they work together.
42 biomarkers identify the specific hormonal drivers of your dysfunction. Ongoing monitoring tracks your restoration as hormones recalibrate.
The programPT-141 acts on the central nervous system to restore desire independent of vascular function. Prescribed based on your specific hormonal profile.
Explore peptidesTargeted treatments that support vascular health, tissue sensitivity, and functional performance alongside hormonal optimization.
View treatmentsDesire, arousal, performance, and satisfaction each depend on different hormonal drivers — all interacting simultaneously. CLARITY maps the full hormonal network so your provider can address the actual cause, not just manage the symptom with a prescription.
Start With a ConversationTestosterone drives desire and arousal in both men and women. Estrogen maintains tissue health and sensitivity. DHEA serves as a precursor to both. Thyroid hormones affect metabolic energy and vascular response. Cortisol, when chronically elevated, suppresses all reproductive hormones. We test all of these in a single comprehensive panel.
Absolutely. Female sexual dysfunction is overwhelmingly hormonal — driven by declining testosterone, estrogen fluctuation, progesterone deficiency, and cortisol elevation. It is underdiagnosed because standard panels rarely test the hormones that drive female desire and arousal.
ED medications address blood flow — one component of sexual function. They do not address the hormonal causes of low desire, impaired arousal, or reduced sensitivity. We identify and treat the upstream hormonal dysfunction that drives sexual health — not just the downstream symptom.
Most patients notice changes in desire and energy within 2-4 weeks of starting hormonal optimization. Full restoration of sexual function typically unfolds over 6-12 weeks as hormone levels stabilize and receptor sensitivity improves.
A private consultation is the first step.
Get the Real Answer